Answers are grounded in this paper and cite their sources.
Open Access Original Research Paper Ischemia Modified Albumin and C-Reactive Protein in Children with β-Thalassemia Major: A Cross Sectional Comparative Study Authors: Rama Kumari Badyal1*, Navdeep Goyal2, Harpal Singh³, Kuldip Singh⁴, Rajesh Prasad Jayaswal5, Baljinder Kaur6 1MD, DNB, Associate Professor, Department of Pathology, Government Medical College, First Floor, GMC, Patiala, Punjab 147001, India. ORCID iD: 0000-0002-7715-664X 2PG Student, Department of Pathology, Government Medical College, First Floor, GMC, Patiala, Punjab 147001, India. ORCID iD: 0009-0004-0625-3663 ³MD, Professor & Head, Department of Pathology, Government Medical College, First Floor, GMC, Patiala, Punjab 147001, India. ORCID iD: 0000-0002-6670-3353 ⁴PhD Biochemistry, Professor, Department of Biochemistry, Government Medical College, First Floor, Patiala, Punjab 147001, India. ORCID iD: 0000-0003-0399-5472. 5MSc MLT, Associate Professor, Department of Medical Laboratory Sciences, University Institute of Allied Health Sciences, Chandigarh University, Mohali, Punjab 140413, India. ORCID iD: 0000-0001-7158-5630. 6MD Paediatric, Professor & Head, Professor and Head, Department of Paediatric, Rajindra Hospital Patiala-147002, Punjab India. ORCID iD: 0009-0003-7046-2024 Corresponding Author: Rama Kumari Badyal, MD, DNB Pathology, Department of Pathology, Government Medical College, First Floor, GMC, Patiala, Punjab 147001, India. DOI: https://doi.org/10.5281/zenodo.24270758 Received: 03 October 2026, Revised: 18 October 2026, Accepted: 04 November 2026, Online First: 18 November 2026 ABSTRACT Objectives: Ischemia-modified albumin (IMA) and C-reactive protein (CRP) are laboratory indicators of oxidative stress and inflammation. This study compared serum IMA and CRP levels between children with β-thalassemia major and healthy controls and examined their association with ferritin concentration and iron-chelation regimen. Materials and Methods: This hospital-based cross-sectional analytical study included 70 children with β-thalassemia major and 70 age- and sex-matched healthy controls at a tertiary care institution. Blood samples from patients were collected before scheduled transfusion. Hematological and biochemical variables, including serum ferritin, CRP and IMA, were analyzed using standard laboratory procedures. Results: Children with β-thalassemia major had significantly lower hemoglobin and red blood cell counts and significantly higher liver enzymes, serum ferritin, CRP and IMA than controls. Mean ferritin was 599.13 ± 156.20 ng/mL in cases and 92.07 ± 14.26 ng/mL in controls. Mean CRP and IMA were 17.48 ± 16.01 mg/dL and 24.11 ± 2.59 U/mL, respectively, in cases compared with 5.83 ± 7.98 mg/dL and 19.13 ± 1.33 U/mL in controls (all p < 0.0001). Children receiving deferiprone showed lower CRP and IMA levels than those receiving deferasirox. Conclusion: Children with β-thalassemia major showed increased iron burden, inflammation and oxidative stress. IMA and CRP may serve as supportive laboratory indicators of disease burden, but longitudinal studies are required before predictive clinical use can be recommended. Keywords: β-thalassemia major; ischemia-modified albumin; C-reactive protein; ferritin; oxidative stress; inflammation INTRODUCTION Thalassemia comprises inherited hematological disorders characterized by reduced or absent globin-chain synthesis and is broadly classified into α- and β-thalassemia according to the affected chain [1, 2]. β-Thalassemia major (β-TM) results from impaired β-globin synthesis, accumulation of excess α-globin chains, ineffective erythropoiesis and chronic hemolysis [3, 4]. In India, the burden of β-thalassemia varies considerably across regions and communities, emphasizing the need for laboratory-based monitoring strategies that are feasible in routine clinical settings [5, 6]. Repeated transfusion, iron overload and altered antioxidant capacity contribute to oxidative injury in β-TM [7]. Albumin is the major plasma protein involved in oncotic balance and transport functions [8]. Under ischemic and oxidative conditions, the N-terminal metal-binding capacity of albumin is altered, generating ischemia-modified albumin (IMA), a marker that has been investigated in conditions associated with oxidative stress [9-11]. C-reactive protein (CRP) is a widely used inflammatory marker and may help characterize the inflammatory milieu in transfusion-dependent thalassemia [12, 13]. Although iron overload is routinely assessed using ferritin, the combined evaluation of ferritin with IMA and CRP may provide additional insight into the oxidative and inflammatory burden in children with β-TM. However, such biomarkers should not be interpreted as direct indicators of cardiovascular disease unless supported by dedicated clinical or imaging assessment. The present study aimed to compare serum CRP and IMA levels between children with β-thalassemia major and healthy controls and to examine their association with ferritin levels and iron-chelation therapy. MATERIALS AND METHODS Study design and setting This hospital-based cross-sectional analytical study was conducted in the Department of Pathology in collaboration with the Departments of Biochemistry and Paediatrics, Government Medical College & Rajindra Hospital, Patiala, Punjab, India. Participants were recruited consecutively from the pediatric outpatient department, inpatient wards and transfusion services during the study period. Participants The study included 70 children diagnosed with β-thalassemia major and 70 age- and sex-matched apparently healthy controls. Among the cases, 18 children were newly diagnosed during the study period. Written informed consent was obtained from the parents or legal guardians of all participants. Eligibility criteria Children with β-thalassemia major diagnosed by hemoglobin electrophoresis and high-performance liquid chromatography (HPLC) were eligible for inclusion. Children were excluded if they had chronic kidney disease, hepatitis, cardiovascular disease, diabetes mellitus, obesity or another chronic illness likely to confound inflammatory or oxidative-stress markers. Children whose parents or legal guardians did not provide consent were also excluded. Clinical and laboratory assessment A structured clinical history was obtained for each participant, including age, age at disease onset, transfusion frequency and chelation therapy. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared, and nutritional status was interpreted using age- and sex-appropriate pediatric BMI reference standards. A 5 mL venous blood sample was collected under aseptic precautions before the scheduled blood transfusion in the case group. Blood was divided into an EDTA tube for complete blood count and a plain tube for serum separation. The plain tube was allowed to clot for 30 min at room temperature and centrifuged at 3000 rpm for 10 min. Serum was separated into aliquots; one aliquot was used for same-day CRP estimation and another was stored at −20°C until IMA analysis. Serum IMA was measured using a commercially available enzyme-linked immunosorbent assay kit according to the manufacturer’s instructions. CRP was determined by latex agglutination using standard laboratory procedures. Internal quality-control procedures were followed for all assays. Outcome variables The primary outcome variables were serum CRP and IMA levels. Secondary variables included serum ferritin, hematological indices, liver-function parameters, renal-function parameters, transfusion frequency and chelation-therapy status. Reference intervals were interpreted according to laboratory and kit-manufacturer standards. Statistical Analysis Data were analyzed using IBM SPSS Statistics version 22.0 (IBM Corp., Armonk, NY, USA). Distribution normality was assessed using the Shapiro-Wilk test. Continuous variables were summarized as mean ± standard deviation or median with interquartile range, as appropriate. Between-group comparisons were performed using the independent Student’s t-test for normally distributed variables and the Mann-Whitney U test for non-normally distributed variables. Categorical variables were compared using the Chi-square test or Fisher’s exact test. A two-tailed p value <0.05 was considered statistically significant. RESULTS Baseline characteristics The mean age of children with β-thalassemia major was 7.46 ± 4.90 years compared with 7.00 ± 4.76 years among controls; the difference was not statistically significant (p = 0.5741). Both groups had equal sex distribution, with 35 males and 35 females in each group. Mean BMI was significantly lower in the case group than in controls (17.76 ± 0.57 vs. 18.39 ± 1.20 kg/m²; p < 0.0001). Detailed baseline characteristics are shown in Table 1. Table 1. Baseline characteristics of children with β-thalassemia major and healthy controls Parameters Variables Case group (n=70) Control group (n=70) Age group (years) ≤5 31 (44.28%) 35 (50%) 6-10 18 (25.71%) 17 (24.28%) 11-15 15 (21.43%) 13 (18.57%) >15 6 (8.57%) 5 (7.14%) Mean ± SD 7.46 ± 4.90 7.00 ± 4.76 Range 1-16 1-16 p value 0.5741 (NS) Gender Male 35 (50%) 35 (50%) Female 35 (50%) 35 (50%) p value 0.8657 (NS) BMI (kg/m²) Underweight 63 (90%) 36 (51.43%) Normal nutritional status 7 (10%) 34 (48.57%) Mean ± SD 17.76 ± 0.57 18.39 ± 1.20 p value 0.0001 (HS) BMI, body mass index; SD, standard deviation; NS, not significant; HS, highly significant. BMI categories were interpreted using age- and sex-appropriate pediatric reference standards. Transfusion and chelation profile Among children with β
No takes yet. Share an insight, caveat, or question.
Rama Kumari Badyal1*, Navdeep Goyal2, Harpal Singh³, Kuldip Singh⁴, Rajesh Prasad Jayaswal5, Baljinder Kaur6 (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: